Effect of histidine on autotaxin activity in experimentally induced liver fibrosis

Journal of Biochemical and Molecular Toxicology

Volumn 25, Issue 3, 2011, Pages 143-150

  El Batch, Manal ^a   Ibrahim, Wafaa ^a   Said, Soha ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

Autotaxin; Histidine; Liver Fibrosis; Thioacetamide; Total Anti Oxidant Capacity

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; AUTOTAXIN; COLLAGEN; GAMMA GLUTAMYLTRANSFERASE; HISTIDINE; HYDROXYPROLINE; LIVER ENZYME; LYSOPHOSPHATIDIC ACID; THIOACETAMIDE; TOTAL ANTIOXIDANT CAPACITY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; COLLAGEN SYNTHESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HISTOPATHOLOGY; LIVER FIBROSIS; LIVER PROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN TARGETING; RAT; TREATMENT DURATION;

ANIMALS; HEPATOCYTES; HISTIDINE; LIVER; LIVER CIRRHOSIS; PHOSPHORIC DIESTER HYDROLASES; RATS; RATS, WISTAR; THIOACETAMIDE;

RATTUS;

EID: 79958802321     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20370     Document Type: Article

References (43)

1. Zou Y, Yang Y, Li J, Wu Q, Li WP, Lu JT, Roberts M. Potential therapeutic effects of a traditional Chinese formulation, BJ-JN, on liver fibrosis induced by carbon tetrachloride in rats. J Ethnopharmacol 2008;120:452-457.
2. So E, Wong K, Huang T, Tasi S, Liu C. Tetramethylpyrazine protects mice against thioacetamide-induced acute hepatotoxicity. J Biomed Sci 2002;9:410-414.
3. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007;117:524-529.
4. Watterson K, Lanning D, Diegelmann R, Spiegel S. Regulation of fibroblast functions by lysophospholipid mediators: Potential roles in wound healing. Wound Repair Regen 2007;15:607-616.
5. Georas S. Lysophosphatidic acid and autotaxin: Emerging roles in innate and adaptive immunity. Immunol Res 2009;45(2-3):229-238.
6. Emerit J, Samuel D, Pavio N. Cu-Zn super oxide dismutase as a potential antifibrotic drug for hepatitis C related fibrosis. Biomed Pharmacother 2006;60(1):1-4.
7. Giganti A, Rodriguez M, Fould B, Moulharat N, Cogé F, Chomarat P, Galizzi J, Valet P, Saulnier-Blache J, Boutin JA, Ferry G. Murine and human autotaxin alpha, beta, gamma isoforms: Gene organization, tissue distribution and biochemical characterization. J Biol Chem 2008;283:7776-7789.
8. Zeng Y, Kakehi Y, Nouh M, Tsunemori H, Sugimoto M, Wu X. Gene expression profiles of lysophosphatidic acid related molecules in the prostate: Relevance to prostate cancer and benign hyperplasia. Prostate 2009;69:283-292.
9. Baumforth K, Flavell J, Reynolds G, Davies G, Pettit T, Wei W, Morgan S, Stankovic T, Kishi Y, Arai H, Nowakova M, Pratt G, Aoki J, Wakelam MJ, Young LS, Murray PG. Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells. Blood 2005;106:2138-2146.
10. Mehmetçik G, Özdemirler G, Toker NK, Cevikbas U, Uysal M. Role of carnosine in preventing thioacetamide-induced liver injury in the rat peptides. Peptides 2008;29(3):425-429.
11. Ukeda H, Hasegawa Y, Harada Y, Sawamura M. Effect of carnosine and related compounds on the inactivation of human Cu, Zn superoxide dismutase by modification of fructose and glycolaldehyde. Biosci Biotechnol Biochem 2002;66:36-43.
12. Wade A, Trucker H. Antioxidant characteristics of l-histidine. J Nutr Biochem 1998;9:308 -315.
13. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Clin Path 1957;28(1):56-63.
14. Saw M, Stromme J, Iondon J, Theodorsen L. IFCC method for γ-glutamyl transferase. (γ-glutamyl-peptide: Amino acid γ-glutamyl transferase, EC 2.3.2.2). Clin Chem Acta 1983;135:315-338.
15. Sajdok J, Jandus J, Valentova O, Novotna Z, Kas J, Daussant J. A microplate technique for phospholipase D activity determination. Anal Chim Acta 1995;315:109-112.
16. Oliveira G, Filho J, Chaves M, Azevedo W, Carvacho L. Enzyme immobilization on anodic aluminum oxide/polyethyleneimino or polyaniline composite. Reactive and functional polymers 2008;68:27-32.
17. Benzie I, Strain J. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: The FRAP assay. Anal Biochem 1996;239:70-76.
18. Bergman I, Loxley R. Two improved and simplified methods for spectrophotometric determination of hydroxyproline. Anal Chem 1963;35:1961-1965.
19. Medugorac I. Collagen content in different areas of normal and hypertrophied rat myocardium. Cardiovasc Res. 1980;14(9):551-554.
20. Sehrawat A, Khan TH, Prasad L, Sultana S. Butea monosperma and chemomodulation: Protective role against thioacetamide-mediated hepatic alterations in Wistar rats. Phytomedicine 2006;13:157-163.
21. Uskukovic-Markovic S, Milenkovic M, Topic A, Kotur-Stevuljevic J, Stefanovic A, Antic-Stankovic J. Protective effects of tungstophosphoric acid and sodium tungstate on chemically induced liver necrosis in Wistar rats. J Pharm Pharm Sci 2007;10:340-349.
22. Amin A, Ghoneim MD. Zizyphus spinachristi protects against carbon tetrachloride-induced liver fibrosis in rats. Food Chem Toxicol 2009;47:2111-2119.
23. Wang X, Lu Y, Cederbaum AI. Induction of cytochrome P450 2E1 increases hepatotoxicity caused by Fas agonistic Jo2 antibody in mice. Hepatology 2005;42, 400-410.
24. Hanauske-Abel H. Fibrosis of the liver, representative molecular elements and their emerging role as anti-fibrotic targets. In Zakim D, Boyer TD, editors. Hepatology 2003: A textbook of liver disease: Philadelphia, PA: WB Saunders; pp. 347-394.
25. Lai J, Hsieh W, Fang H, Lin W. The protective effects of a fermented substance from Saccharomyces cerevisiae on carbon tetrachloride-induced liver damage in rats. Clin Nutr 2009;28:338-345.
26. Das D, Pemberton P, Burrows P, Gordon C, Smith A, McMahon R, Warnes T. Antioxidant properties of colchicine in acute carbon tetrachloride induced rat liver injury and its role in the resolution of established cirrhosis. Biochim Biophys Acta 2000;1502:351-362.
27. Peres W, Tunon M, Collado P, Herrmann S, Marroni N, Gonzalez-Gallego J. The flavonoid quercetin ameliorates liver damage in rats with biliary obstruction. J Hepatol 2000;33:742-750.
28. Vendemiale G, Grattagliano I, Caruso M, Serviddio G, Valentini AM, Pirrelli M, Altomare E. Increased oxidative stress in dimethylnitrosamine induced liver fibrosis in the rat: Effect of N-acetylcysteine and interferon-alpha. Toxicol Appl Pharm 2001;175:130-139.
29. Benzie I, Strain J. Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Meth Enzymol 1999;299:15-27.
30. Horoz M, Bolukbas C, Bolukbas F, Sabuncu T, Aslan M, Sarifakiogullari S, Gunaydin N, Erel O. Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis. BMC Gastroenterol 2005;5:35.
31. Ikeda H, Watanabe N, Nakamura K, Kume Y, Nakai Y, Fujishiro M, Omata M. Significance of serum autotaxin activity in gastrointestinal disease. Rinsho Byori. 2009;57(5):445-449(abstract).
32. Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Aoki J, Hama K, Aoki J, Hama K, Okudaira S, Tanaka M, Tomiya T, Yanase M, Tejima K, Nishikawa T, Arai M, Arai H, Omata M, Fujiwara K, Yatomi Y. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J Clin Gastroenterol 2007;41(6):616-623.
33. Yanase M, Ikeda H, Ogata I, Matsui A, Noiri E, Tomiya T, Arai M. Functional diversity between Rho-kinase and MLCK-mediated cytoskeletal actions in a myofibroblast-like hepatic stellate cell line. Biochem Biophys Res Commun 2003;305(2):223-228.
34. Ikeda H, Nagashima K, Yanase M, Tomiya T, Arai M, Inoue Y, Tejima K. Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2003;285(5):G880-G886.
35. Ikeda H, Yatomi Y, Yanase M, Satoh H, Nishihara A, Kawabata M, Fujiwara K. Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture. Biochem Biophys Res Commun 1998;248(2):436-440.
36. Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Tomiya T, Tejima K, Nishikawaa T, Araic M, Yanased M, Aokie J, Araie H, Omataa M, Fujiwaraf K, Yatomib Y. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity. Life Sci 2007; (81):1009-1015.
37. Liu W, Liu T, Yin M. Beneficial effects of histidine and carnosine on ethanol-induced chronic liver injury. Food Chem Toxicol 2008;6:1503-1509.
38. Clair T, Koh E, Ptaszynska M, Bandle R, Liotta L, Schiffmann E, Stracke M. l-Histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin. Lipids Health Dis 2005;4:5.
39. Rauen U, Klempt S, Groot H. Histidine induced injury to cultured liver cells, effects of histidine derivatives and of iron chelators. Cell Mol Life Sci 2007;64:192-205.
40. 2-induced damage and their protection by nitroxides. Biochim Biophys Acta 2001;1525:70-76.
41. Babizhayev M, Seguin M, Gueyne J, Evstigneeva R, Ageyeva E, Zheltukhina G. l-Carnosine (β-alanyl-l-histidine) and carcinine (β-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities. J Biochem 1994;304:509-516.
42. Cantoni O, Giacomoni P. The role of DNA damage in the cytotoxic response to hydrogen peroxide-histidine. Gen Pharmacol 1997;29:513-516.
43. Mozdzan M, Szemraj J, Rysz J, Nowak D. Antioxidant properties of carnosine re-evaluated with oxidizing systems involving iron and copper ions. Basic Clin Pharmacol Toxicol 2005;96(5):352-360.